Most Recent
Saying the interests of class action members "must be given primacy", a judge has rejected the first bid for a group costs order in a class action since contingency fee legislation passed in Victoria.
A Federal Court judge has taken a swipe at new regulations that require class action funding arrangements to be registered as managed investment schemes, saying it was difficult to reconcile the new rules with the class action regime.
Despite COVID-19 case numbers in Australia hitting historic highs and the threat of an economic recession, law firms are cautiously optimistic about their ability to weather the storm without redundancies or reductions in staff pay.
Qantas Airways is seeking to overturn a Federal Court finding that its decision to axe 2,000 ground staff and replace them with labour hire workers during the COVID-19 pandemic was made partially to stop workers engaging in industrial action.
Allianz Australia and its travel insurance unit AWP Australia have been hit with $1.5 million in penalties in ASIC’s case alleging the insurance companies misled customers while selling travel insurance on Expedia websites.
A former Deutsche Bank executive named in a criminal cartel case over a $2.5 billion ANZ share placement says the charges against him are defective and should be quashed.
AMP has hit back at fees for no service court proceedings brought by ASIC, arguing it was legally entitled to charge customers premiums and advice fees for life insurance after they died.
7-Eleven has told a court it is willing to negotiate a deal with Seven over the 7NOW logo, a trade mark the TV network recently lost after a successful challenge by the convenience store chain.
National Australia Bank has been hit with a $18.5 million fine after admitting to allegations by ASIC that it failed to adequately disclose its adviser fees for five years.
Swiss pharmaceutical company Biogen is seeking a court order blocking an Australian generic drug manufacturer from selling a cheap multiple sclerosis drug it claims infringes its patent for medicine Tecfidera, a court has heard.